Administer a compliant and successful Expanded Access program
Expanded Access Programs (including Named Patient, Early Access, Compassionate Use and Temporary Authorisation for Use (ATU) programs), are being designed to provide patient and physician access to investigational drugs outside
of clinical trials and prior to marketing approval and launch. These programs are improving access to drugs for the fulfillment of unmet patient needs in an ethical way.
Download The Data Sheet